S. Mullerhulsbeck et al., MR-IMAGING SIGNAL-INTENSITY ABNORMALITIES AFTER PLACEMENT OF ARTERIALENDOPROSTHESES, American journal of roentgenology, 169(3), 1997, pp. 743-748
OBJECTIVE. Our objectives were to describe changes in T2-weighted MR i
mages of patients who had undergone implantation of an endoluminal ste
nt-graft and determine the rate of early reocclusion in patients with
abnormal MR findings. SUBJECTS AND METHODS. Twenty-nine patients with
26 occlusions (average length, 8.7 +/- 5.6 cm) and three dissections o
f the superficial femoral artery were treated with 45 endoluminal sten
t-grafts. T2-weighted gradient-echo and T2-weighted turbo spin-echo MR
images were obtained for all patients at 48 hr and at 4 weeks after s
tent-graft placement. We reviewed the MR imaging studies to assess the
extent and severity of tissue alteration at the site of stent-graft i
mplantation. RESULTS. Technical success rate of stent-graft placement
was 100%. Three signal-intensity patterns were seen on MR images obtai
ned at 48 hr: normal signal intensity (n = 8), subtle perivascular sig
nal-intensity abnormalities at the site of stent-graft implantation (n
= 11), and extensive signal-intensity abnormalities from the adductor
canal to the subcutis (n = 10). Twenty of 21 patients with abnormal s
ignal intensity on MR images had fevers and pain at the implantation s
ite. Clinical signs of deep vein thrombosis, a diagnosis excluded on t
he basis of phlebography, were seen in the 10 patients with extensive
signal-intensity abnormalities. In two of these 10 patients, the super
ficial femoral artery reoccluded within 4 weeks of implantation. MR im
ages obtained at 4 weeks showed no signal-intensity abnormalities in a
ny of the 29 patients. CONCLUSION. MR findings of perivascular signal-
intensity abnormalities after implantation of endoluminal stent-grafts
are associated with clinical complications such as local pain and fev
er. Care should be taken to avoid confusing the clinical signs of the
postimplantation syndrome at 48 hr with deep vein thrombosis.